Intrinsic Value of S&P & Nasdaq Contact Us

PolyPid Ltd. PYPD NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • IL • USD

SharesGrow Score
56/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.50
+114.9%

PolyPid Ltd. (PYPD) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 8 recommend buying, 1 recommend holding, and 0 recommend selling.

The analyst consensus price target for PYPD is $9.50, representing a +114.9% upside from the current price of $4.42. Price targets range from a low of $9.00 to a high of $10.00.

Analyst Consensus — PYPD

Buy
Strong Buy
0
Buy
8
Hold
1
Sell
0
Strong Sell
0
9 analysts
Price Targets
Consensus$9.50
High$10.00
Low$9.00
Median$9.50
Last Month Avg-
Last Quarter Avg-
Last Year Avg$9.00
All-Time Count2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message